Keywords: sep, launches, plenaxis, germany, uk-based, speciality, european

SEP launches Plenaxis in Germany

Article | 03 March 2008

Print This

UK-based Speciality European Pharma has launched its drug Plenaxis (abarelix for injection) in Germany. The agent is used to treat ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in